Singapore markets open in 2 hours 34 minutes
Straits Times Index
3,330.09 +11.64 (+0.35%) S&P 500
5,306.04 +1.32 (+0.02%) Dow
38,852.86 -216.73 (-0.55%) Nasdaq
17,019.88 +99.09 (+0.59%) Bitcoin USD
68,539.11 -1,017.15 (-1.46%) CMC Crypto 200
1,485.72 -10.74 (-0.72%)
MRK Jan 2025 100.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:05PM EDT. Market open.
| Previous close | 31.90 |
| Open | 31.90 |
| Bid | 28.20 |
| Ask | 29.25 |
| Strike | 100.00 |
| Expiry date | 2025-01-17 |
| Day's range | 31.90 - 31.90 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.49k |
Business WireMerck Announces Third-Quarter 2024 Dividend
RAHWAY, N.J., May 28, 2024--Merck Announces Third-Quarter 2024 Dividend
BenzingaMerck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Editor’s Note: The title of the story is updated to correct the reference to ‘Breast’ cancer instead of ‘Lung’ cancer. Tuesday, Merck & Co Inc (NYSE:MRK) released topline data from hase 3 KEYNOTE-522 trial of Keytruda in high-risk early-stage triple-negative breast cancer (TNBC). The study evaluated Keytruda in combination with chemotherapy as a pre-operative (neoadjuvant) treatment and then continuing as a single agent after surgery (adjuvant). The study met its overall survival (OS) endpoint.
Simply Wall St.Is Merck & Co., Inc.'s (NYSE:MRK) Recent Performance Underpinned By Weak Financials?
Merck (NYSE:MRK) has had a rough month with its share price down 1.3%. To decide if this trend could continue, we...
© 2024 Yahoo. All rights reserved.